Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRESIDEX: Dexamethasone for PRES in Eclampsia
NCT02027272Terminated
- Sponsor
- University of Mississippi Medical Center
- Start
- Feb 2012
- Primary completion
- Dec 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial in Posterior Reversible Encephalopathy Syndrome (PRES) comparing Dexamethasone with Placebo (2 arms). Primary endpoint: Time to resolution of Posterior Reversible Encephalopathy Syndrome at 36 months. Started Feb 2012; status: terminated.
02
Drugs
dexamethasone
03
Conditions
Posterior Reversible Encephalopathy Syndrome (PRES)
Beyond the preview
Go deeper on NCT02027272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02027272.